Giulia Arrivi

Prevention and management of hormonal crisis in neuroendocrine tumors undergoing PRRT (peptide receptor radionuclide therapy): a systematic review

Peptide receptor radionuclide therapy (PRRT) is an established treatment of advanced well-differentiated neuroendocrine tumors (NETs) expressing somatostatin receptors. Although generally well tolerated, PRRT may precipitate or exacerbate pre-existing hormonal syndromes in patien...